This combination tablet contains empagliflozin and linagliptin, two medicines that lower blood sugar in type 2 diabetes through complementary mechanisms. Empagliflozin helps the kidneys remove excess glucose through urine, while linagliptin helps the body release more insulin after meals. Together they improve blood sugar control when diet, exercise, and a single medicine are not enough. It is taken once daily with or without food.
Purpose
Helps control blood sugar levels in adults with type 2 diabetes.
Ingredients
Empagliflozin 10mg, Linagliptin 5mg (pharmevo.biz)
Warnings
Not for use in type 1 diabetes or diabetic ketoacidosis | May increase risk of urinary tract and genital infections | Inform your doctor if you have kidney impairment | Stay well hydrated, especially in hot weather or if unwell | Not recommended during pregnancy or breastfeeding
Side Effects
Urinary tract infections | Genital yeast infections | Increased urination | Thirst | Low blood sugar when combined with other diabetes medicines
Storage Instructions
Store below 30°C in a dry place, away from direct sunlight, out of reach of children.
| Brand | Pharmevo Pharmaceuticals |
|---|---|
| Status | Active |
Customer reviews
Related products
Estar 10mg (10 Tablets / Pack)
Rast 20mg (30 Tablets / Pack)
Silagro 100mg (8 Tablets / Pack)
Arysa 40mg (14 Capsules / Pack)
Arysa 20mg (14 Capsules / Pack)
Dafo Mxr 5/500mg (14 Tablets / Pack)
Dafo Mxr 10/500mg (14 Tablets / Pack)
